港股異動 | 港交所(0388.HK)漲逾2% 林鄭月娥《施政報告》或將提擴大“互聯互通”
格隆匯11月24日丨港交所高開高走,現漲逾2%,報385港元,總市值4881億港元。星島日報引述消息稱,香港將擴大與內地股票互聯互通的涵蓋範圍,將包括在香港上市的生物科技股及二次上市股份。措施得到內地政府支持,預計將由行政長官林鄭月娥在週三發表《施政報告》時宣佈。此外,香港交易所於昨日(11月23日)推出了恆生科技指數期貨合約,並將於明年1月18日推出恆生科技指數期權,與香港交易所旗艦的恆生指數及恆生中國企業指數產品互補。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.